The invention

The invention

Innovative intranasal delivery of peptide for enhanced disease management

M: Medicine – Surgery – Orthopaedics – Material for disabled

Informations

Stand number
C71
Exhibition class
M: Medicine – Surgery – Orthopaedics – Material for disabled
Technical description
Intranasal semaglutide compositions to treat diabetes, obesity, and neurodegenerative diseases. It improves absorption by bypassing gastrointestinal degradation, avoids repeated injections, and enhances patient compliance
Simplified description
This invention introduces an easier way to use semaglutide, a treatment for diabetes, obesity, and neurodegenerative diseases. By delivering it through the nose, it avoids stomach breakdown, reduces the need for injections, and makes it simpler for patients to stick to their treatment plan.

Inventors


Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.